Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prostate and testis expressed protein 3 (PATE3) is a member of the Ly-6/uPAR/three-finger protein superfamily, characterized by a conserved arrangement of 10 cysteine residues forming a three-fingered structural motif[1][2]. It is secreted and primarily found in the male reproductive tract (prostate, testis, seminal vesicle, epididymis), and its expression is androgen-dependent[1][2]. PATE3 exhibits antimicrobial activity, likely contributing to innate immunity and defense mechanisms in the reproductive tract. It may also participate in sperm maturation and has a structure resembling certain neurotoxins (e.g., bucandin), suggesting potential neuromodulatory functions, though these roles are not fully defined[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prostate and testis expressed protein 3 (PATE3).